Intersol Solution
Product Images NDC 0942-9605

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Intersol (NDC 0942-9605). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fenwal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6b7800slbl (Export 00)

Label for InterSol Solution Platelet Additive 3 with Twist-off Port, containing 800 mL solution. The product is labeled for intravenous use and identifies active ingredients including 305 mg Dibasic Sodium Phosphate, 93 mg Monobasic Sodium Phosphate, 318 mg Sodium Citrate, 442 mg Sodium Acetate, and 452 mg Sodium Chloride per 100 mL. Manufactured by Fenwal International Inc., Puerto Rico, and distributed by Fresenius Kabi AG, Germany. Includes storage instructions and RX only designation.*

FDA Label Image

Symbols6b7800s (Image 01)

This image shows a list of symbols with definitions used for InterSol Platelet Additive 3 solution packaging. Symbols indicate instructions such as sterilization method, non-pyrogenic fluid path, expiration date, fragility, proper handling, and regulatory notices including that the product is for US prescription use only.*

FDA Label Image

Mf6b7800s (Image 02)

FDA Label Image

Table (Table1)

A data table titled 'In Vitro Assessments, AMICUS Separator-derived, leukoreduced platelets,' comparing parameters for InterSol and Plasma on various days. It lists values such as glucose, lactate, pO2, pCO2, bicarbonate, lactate dehydrogenase, CD62 expression, morphology score, hypotonic shock response, and extent of shape change, with means and standard deviations for each parameter.*

FDA Label Image

Table (Table2)

A data table titled 'Table 2: In Vitro Assessments — Irradiated and Non-Irradiated Platelets, AMICUS Separator-derived, leukoreduced platelets.' It compares various parameters such as glucose, lactate, pO2, pCO2, bicarbonate, lactate dehydrogenase, CD62 expression, morphology score, hypotonic shock response, and extent of shape change measured on day 5 between InterSol Irradiated and Non-Irradiated platelet solutions, showing mean values and standard deviations for each parameter.*

FDA Label Image

Table3 (Table3)

A data table titled 'In Vitro Assessments, TRIMA ACCEL-derived, Leukoreduced Platelets' presenting comparisons between InterSol and Plasma across several parameters such as Glucose, Lactate, pO2, pCO2, Bicarbonate, Lactate Dehydrogenase, P-selectin, Morphology, Hypotonic Shock Response, and Extent of Shape Change with mean values, standard deviations, and sample sizes shown by day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.